Highlights and Quick Summary
- Annual Depreciation/Fixed assets for 2021 was 1.41 (a -48.63% decrease from previous year)
- Annual Depreciation/Fixed assets for 2020 was 2.74 (a 81.62% increase from previous year)
- Annual Depreciation/Fixed assets for 2019 was 1.51 (a 20.37% increase from previous year)
- Twelve month Depreciation/Fixed assets ending September 30, 2022 was 2.64 (a 20.59% increase compared to previous quarter)
- Twelve month trailing Depreciation/Fixed assets increased by 87.51% year-over-year
Trailing Depreciation/Fixed assets for the last four month:
| 30 Sep '22 | 30 Jun '22 | 31 Mar '22 | 31 Dec '21 |
|---|---|---|---|
| 2.64 | 2.19 | 1.82 | 1.41 |
Visit stockrow.com/BDSX
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Depreciation/Fixed assets of Biodesix, Inc.
Most recent Depreciation/Fixed assetsof BDSX including historical data for past 10 years.Interactive Chart of Depreciation/Fixed assets of Biodesix, Inc.
Biodesix, Inc. Depreciation/Fixed assets for the past 10 Years (both Annual and Quarterly)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2021 | – | – | – | – | 1.41 |
| 2020 | – | – | – | – | 2.74 |
| 2019 | – | – | – | – | 1.51 |
| 2018 | – | – | – | – | 1.25 |
Business Profile of Biodesix, Inc.
Sector: Healthcare
Industry: Diagnostics & Research